Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
KEWAUNEE SCIENTIFIC CORP /DE/
Bear Case (25th pct.)
24.6% vs price
Base Case (Median)
52.6% vs price
Bull Case (75th pct.)
93.7% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $49.83 | 37.8% | High (40%) |
| PE Comparable | $60.53 | 67.4% | Medium (25%) |
| Graham Number | $43.48 | 20.2% | Medium (30%) |
| EV/EBITDA | $73.23 | 102.5% | Medium (20%) |
| EV/FCF | $95.46 | 163.9% | Medium (20%) |
| Earnings Power Value | $41.70 | 15.3% | Medium (50%) |
Based on 6 out of 7 methods, KEQU appears undervalued at the current price of $36.17. The base case fair value of $55.18 implies 52.6% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.